Empa - the place where innovation starts
Empa is the research institute for materials science and technology of the ETH Domain and conducts cutting-edge research for the benefit of industry and the well-being of society.
Empa’s Laboratory of Biomimetic Membranes and Textiles is offering
Our laboratory. Empa’s Laboratory of Biomimetic Membranes and Textilesaims to develop materials and systems for the protection and optimal performance of the human body. A special focus is to investigate the interactions between materials and human skin, as well as to optimize the protection and ergonomics of systems. The products developed in collaboration with industry are used in the fields of occupational safety, sport and medical applications. We also develop non-invasive materials and systems to help maintain the physical integrity or to relieve pain.
Background. Transdermal drug delivery (TDD) is a non-invasive method to deliver moderately lipophilic drugs with a low molecular weight through our largest organ: the skin. Via this pathway, low-bioavailable pharmacological agents with a high first-pass effect are successfully self-administered in lower doses. A main hurdle with TDD is controlling the level of percutaneous drug absorption since the delivery pathway – the human skin – is patient specific and represents a complex physical and biochemical barrier for many drugs. The absorption kinetics depend on the patient and the bio-environment. Furthermore, the transport pathway – the skin – is a multilayered and multiscale structure, reaching from the thick dermis (≈ mm) down to the lipid bilayers in the stratum corneum (≈ nm). To understand all biophysical phenomena occurring during drug uptake and to control these processes better, the transport at all the different length and time-scales needs a more thorough understanding.
Objective. This project aims to develop a multiscale methodology to gain a deeper understanding in TTD and its control. This implies performing finite-element simulations of transdermal drug uptake, to gain access to the macroscale transport behavior of the drug through the skin. Continuum modeling accuracy is enriched by molecular dynamics (MD) simulations. These lower-scale simulations help us to unveil the behavior of drug molecules at the atomic scale (e.g. in lipid bilayers).
Administration. A project duration of 3 years is envisaged to carry out the above research tasks in the form of a PhD thesis. The project is supported by Empa under the supervision of Thijs Defraeye and Riccardo Innocenti Malini, but involves a joint affiliation with ETH Zurich or EPFL. The candidate will perform his research at Empa in St. Gallen. Desired starting date is 1st of April 2019 or upon mutual agreement.
For further information about the position please contact Thijs Defraeye email@example.com and visit our websites www.empa.ch/web/s401 and https://www.empa.ch/web/det and Empa-Video
We look forward to receiving your online application including a letter of motivation, CV including publications and presentations, diplomas with transcripts and contact details of two referees. Please upload the requested documents through our webpage. Applications via email will not be considered.
Empa, Esther Zürcher, Human Resources, Lerchenfeldstrasse 5, 9014 St. Gallen, Switzerland.
|Title||a PhD position titled: Multiscale modeling of transdermal drug delivery|
|Job location||Ueberlandstrasse 129 , CH-8600 Dübendorf|
|Published||February 26, 2019|
|Application deadline||Unspecified deadline|
|Job type||PhD  |
|Fields||Materials Engineering,   Engineering Physics,   Materials Physics,   Molecular Physics  |